柳叶刀·121825

柳叶刀_121825.pdfEditorial Newobesitypill:newhopes,oldfears On Dec 7, 2010, the US Food and Drug Administration thoughts, seizures, and serious cardiovascular effects.The(FDA) Endocrinologic and Metabolic Drugs Advisory FDA committee and the drugs manufacturer, Orexigen, Committee gave a positive recommendation foComment were lowat 6 ,thelatterbeing commensurate withthe Facon T,Mary J, Hulin C,et al forthe Intergroupe Francophone du lower rates seen with VTD in the Cavo trial Myelome.Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone orreduced-intensity autologous stem cell BecaComment Subthreshold depression is common in primary care and CFR and SMAhave received grant support fromthe NationalInstitutes of Health.approached 20 in the MANAS sample.Patients living GilboywFletchchard,uttnllabativea with subthreshold symptoms of depression or anxiety depression: a cumulativ
———— 文字由OCR识别(未校验)，可能存在错字；请以原始完整版为准。